|
Bayes-Genis A, Pascual-Figal D. Making STRONGer the transition phase: personalized GDMT through NT-proBNP monitoring. Eur Heart J. 2023 Aug 14;44(31):2963-2965. doi: 10.1093/eurheartj/ehad356. No abstract available. PubMed PMID: 37220888.
AÑO: 2023; IF: 37.6
|
|
González-Juanatey J.R., Comín-Colet J., Figal D.P., Bayes-Genis A., Cepeda J.M., García-Pinilla J.M., García-Quintana A., Manzano L., Zamorano J.L. Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat. Patient Preference and Adherence. 2023. 17:839-849. 10.2147/PPA.S400403
AÑO: 2023; IF: 2.0
|
|
Pascual-Figal DA, Zamorano JL, Domingo M, Morillas H, Nunez J, Cobo Marcos M, Riquelme-Perez A, Teis A, Santas E, Caro-Martinez C, Pinilla JM, Rodriguez-Palomares JF, Dobarro D, Restrepo-Cordoba MA, Gonzalez-Juanatey JR, Bayes Genis A; DAPA-MODA Study Investigators. Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study. Eur J Heart Fail. 2023 Aug;25(8):1352-1360. doi: 10.1002/ejhf.2884. Epub 2023 Jun 7. PubMed PMID: 37211950.
AÑO: 2023; IF: 16.9
|
|
Stambler BS, Camm AJ, Alings M, Dorian P, Heidbuchel H, Houtgraaf J, Kowey PR, Merino JL, Mondesert B, Piccini JP, Pokorney SD, Sager PT, Verma A, Wharton JM, Bharucha DB, Plat F, Shardonofsky S, Chen M, Ip JE; RAPID Investigators. Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial. Lancet. 2023 Jul 8;402(10396):118-128. doi: 10.1016/S0140-6736(23)00776-6. Epub 2023 Jun 15. PubMed PMID: 37331368.
AÑO: 2023; IF: 98.4
|
|
Palau P, Amiguet M, Dominguez E, Sastre C, Mollar A, Seller J, Garcia Pinilla JM, Larumbe A, Valle A, Gomez Doblas JJ, de la Espriella R, Minana G, Mezcua AR, Santas E, Bodi V, Sanchis J, Pascual-Figal D, Gorriz JL, Bayes-Genis A, Nunez J; DAPA-VO2 Investigators (see Appendix). Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2 ): a randomized clinical trial. Eur J Heart Fail. 2022 Oct;24(10):1816-1826. doi: 10.1002/ejhf.2560. Epub 2022 Jun 6. PubMed PMID: 35604416.
AÑO: 2022; IF: 18.2
|